Molecule Details
| InChIKey | MRXVYOLTKNEJHK-VVOKDJNJSA-M |
|---|---|
| Compound Name | (5R),(6Z)-6-(7-methyl-5,6,7,8-tetrahydroimidazo[1,2-a]pyrazin-2-ylmethylene)-7-oxo-4-thia-1-aza-bicyclo-[3.2.0]hept-2-ene-2-carboxylic acid sodium salt |
| Canonical SMILES | CN1CCn2cc(/C=C3/C(=O)N4C(C(=O)[O-])=CS[C@H]34)nc2C1 |
| Clinical Status | Data-mined Candidate |
| Targets (Human+Pathogen) | 4 |
| Pfam Stratification | Unknown |
| Avg pChEMBL | 7.8 |
| Source | ChEMBL;BindingDB |
2D Structure
Activity Profile
Target Activities (4)
| Target | Gene | Organism | Category | Pfam | pChEMBL | Type | Source |
|---|---|---|---|---|---|---|---|
| P62593 | bla | Escherichia coli | Pathogen | PF13354 | 8.4 | IC50 | ChEMBL;BindingDB |
| P05364 | ampC | Enterobacter cloacae | Pathogen | PF00144 | 8.2 | IC50 | ChEMBL;BindingDB |
| P52663 | nmcA | Enterobacter cloacae | Pathogen | PF13354 | 7.7 | IC50 | ChEMBL;BindingDB |
| P25910 | ccrA | Bacteroides fragilis | Pathogen | — | 6.9 | IC50 | ChEMBL;BindingDB |